Crossref
Caspase-9 rs1052576 Polymorphism is not Associated with Glioblastoma in Turkish Patients
Experimed · 2022
DOI: 10.26650/experimed.1183865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimed, 2022. Verfasst von Deryanaz Billur und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Billur, D., Akdeniz, F. T., Yılmaz, S. G., Barut, Z., Yaltırık, C., & İsbir, T. (2022). Caspase-9 rs1052576 Polymorphism is not Associated with Glioblastoma in Turkish Patients. Experimed. https://doi.org/10.26650/experimed.1183865
Vancouver
Billur D, Akdeniz FT, Yılmaz SG, Barut Z, Yaltırık C, İsbir T. Caspase-9 rs1052576 Polymorphism is not Associated with Glioblastoma in Turkish Patients. Experimed. 2022. doi:10.26650/experimed.1183865
BibTeX
@article{Billur2022,
author = {Billur, Deryanaz and Akdeniz, Fatma Tuba and Yılmaz, Seda Güleç and Barut, Zerrin and Yaltırık, Cumhur and İsbir, Turgay},
title = {Caspase-9 rs1052576 Polymorphism is not Associated with Glioblastoma in Turkish Patients},
journal = {Experimed},
year = {2022},
doi = {10.26650/experimed.1183865}
}
EUVIMED